Novel use of adjuvant proton beam therapy in patient with pelvic renal transplant diagnosed with stage IB3 cervical adenocarcinoma
Cervical adenocarcinoma is the second most common histology of cervical cancer and treatment can involve surgery, radiotherapy, systemic therapy, and any combination of the three. Photon external beam radiation therapy and brachytherapy have been the mainstay of radiation treatment options for cervical cancer. Here, we report a case of a 41-year-old patient who had a prior renal transplant and was diagnosed with early-stage, intermediate-risk adenocarcinoma treated with modified radical hysterectomy plus adjuvant proton-beam therapy and vaginal brachytherapy. Treatment was well tolerated with a disease-free interval of 14-months and preserved renal function.
Authors
- Allison E. Garda (ORCID: https://orcid.org/0000-0002-2170-5427)
- Patrick G. Dean (ORCID: https://orcid.org/0000-0003-2010-0466)
- Jamie Nadine Bakkum-Gamez (ORCID: https://orcid.org/0000-0001-7018-8625)
- Pedro Versuti Del Cioppo Vasques
- Jeremy F Molligan
Institutions
- Mayo Clinic (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Gynecologic Oncology Reports
- Published
- 2024-09-30
- DOI
- https://doi.org/10.1016/j.gore.2024.101520
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Mayo Foundation for Medical Education and Research